Novavax (NASDAQ:NVAX) reported quarterly earnings of $2.93 per share which beat the analyst consensus estimate of $0.71 by 312.68 percent. This is a 379.05 percent increase over losses of $(1.05) per share from the same period last year. The company reported quarterly sales of $666.65 million which beat the analyst consensus estimate of $343.85 million by 93.88 percent. This is a 610.30 percent increase over sales of $93.86 million the same period last year.